Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00550134 · ClinicalTrials.gov registry record
Cognitive Changes Associated With Breast Cancer Treatment
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 53
- Enrollment target
NCT00550134: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00550134 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 53 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00550134 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 53 participants
- Enrollment target
Study Summary
Patients with cancer often complain that their "mind does not seem to be clear." This can be due to stress, depression, anxiety, or physical problems caused by cancer or the treatments used to control symptoms. There are many purposes for this study; one of them is to learn about the effects of cancer treatments on the brain, and another is to identify useful tools to detect these effects. The results of this study may stimulate new research comparing different treatments to the current treatment so the researchers may learn how to treat symptoms more effectively and improve patient quality of life. We would also like to learn more about the effects chemotherapy may have on DNA.
Interventions
- BEHAVIORAL Questionnaires, MRI, Comet assay and Cell senescence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2007-10-24 |
| Est. Completion | 2021-12-28 |
What the finished NCT00550134 record still lists
NCT00550134 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 53 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Questionnaires, MRI, Comet assay and Cell senescence is the first listed.
NCT00550134 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00550134 about?
NCT00550134 is a clinical study titled "Cognitive Changes Associated With Breast Cancer Treatment". Patients with cancer often complain that their "mind does not seem to be clear." This can be due to stress, depression, anxiety, or physical problems caused by cancer or the treatments used to control symptoms. There are many purposes for this study; one of them is to learn about the effects of canc...
What is the current status of trial NCT00550134?
This trial is currently completed. The enrollment target is 53 participants. The study started on 2007-10-24. Estimated completion is 2021-12-28.
What interventions are being tested in trial NCT00550134?
The interventions under investigation include: Questionnaires, MRI, Comet assay and Cell senescence (BEHAVIORAL).
Who is sponsoring clinical trial NCT00550134?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI